Abstract:Piperlongumine (PL) has multiple anticancer effects by targeting different pathways associated with cancer. Pharmaceutical researchers have been trying to optimise the structure of PL‐derivatives to improve their drug‐likeness profiles. Drug chemistry analyses of a large number of PL‐derivatives revealed that most of them showed higher anticancer potency and drug‐ability than the native PL. Piperlongumine, or piplartine (PL), is a bioactive alkaloid isolated from Piper longum L. and a potent phytoconstituent in Indian Ayurveda and traditional Chinese medicine with a lot of therapeutic benefits. Apart from all of its biological activities, it demonstrates multimodal anticancer activity by targeting various cancer‐associated pathways and being less toxic to normal cells. According to their structure–activity relationship (SAR), the trimethylphenyl ring (cinnamoyl core) and 5,6‐dihydropyridin‐2‐(1H)‐one (piperdine core) are responsible for the potent anticancer activity. However, it has poor intrinsic properties (low aqueous solubility, poor bioavailability, etc.). As a result, pharmaceutical researchers have been trying to optimise or modify the structure of PL to improve the drug‐likeness profiles. The present review selected 26 eligible research articles on PL derivatives published between 2012 and 2023, followed by the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) format. We have thoroughly summarised the anticancer potency, mode of action, SAR and drug chemistry of the proposed PL‐derivatives against different cancer cells. Overall, SAR analyses with respect to anticancer potency and drug‐ability revealed that substitution of methoxy to hydroxyl, attachment of ligustrazine and 4‐hydroxycoumarin heterocyclic rings in place of phenyl rings, and attachment of heterocyclic rings like indole at the C7‐C8 olefin position in native PL can help to improve anticancer activity, aqueous solubility, cell permeability, and bioavailability, making them potential leads. Hopefully, the large‐scale collection and critical drug‐chemistry analyses will be helpful to pharmaceutical and academic researchers in developing potential, less‐toxic and cost‐effective PL‐derivatives that can be used against different cancers.

Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer

Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer

Piperlongumine inhibits head and neck squamous cell carcinoma proliferation by docking to Akt

Piperlongumine Induces Gastric Cancer Cell Apoptosis and G2/M Cell Cycle Arrest Both in Vitro and in Vivo.

Piperlongumine Inhibits Migration of Glioblastoma Cells Via Activation of ROS-dependent P38 and JNK Signaling Pathways.

Piperlongumine and its derivatives against cancer: A recent update and future prospective

Network pharmacology-based anti-colorectal cancer activity of piperlonguminine in the ethanolic root extract of Piper longum L

Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway

Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines

Piperine Suppresses Tumor Growth and Metastasis in Vitro and in Vivo in a 4T1 Murine Breast Cancer Model

Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells

Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells

Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP.

Overview of piperlongumine analogues and their therapeutic potential

Elucidation of the Anti-Colon Cancer Mechanism of Phellinus Baumii Polyphenol by an Integrative Approach of Network Pharmacology and Experimental Verification.

Piperlongumine is a ligand for the orphan nuclear receptor 4A1 (NR4A1)

Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells

Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells

Standardized extract and its compounds from fruits of Piper longum suppress MDA-MB-231 cancer stem cells via down-regulation of intracellular signals

Piperlongumine Suppresses Proliferation of Human Oral Squamous Cell Carcinoma through Cell Cycle Arrest, Apoptosis and Senescence

Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway